UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.114

Sortiert nach

Fast Unsupervised Multi-Scale Characterization of Urban Landscapes Based on Earth Observation Data

Remote sensing (Basel, Switzerland), 2021-06, Vol.13 (12), p.2398

2021

Volltextzugriff (PDF)

Complementarity between Textural and Radiometric Indices From Airborne and Spaceborne Multi VHSR Data: Disentangling the Complexity of Heterogeneous Landscape Matrix

Remote sensing (Basel, Switzerland), 2019-03, Vol.11 (6), p.693

2019

Volltextzugriff (PDF)

Monitoring and Characterizing Heterogeneous Mediterranean Landscapes with Continuous Textural Indices Based on VHSR Imagery

Remote sensing (Basel, Switzerland), 2018-06, Vol.10 (6), p.868

2018

Volltextzugriff (PDF)

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3601-3616

1997

Volltextzugriff (PDF)

Integration of ADAS Into One Central Platform Controller

Auto Tech Review, 2016, Vol.5 (7), p.32-35

Lang, Marc

2016

Volltextzugriff (PDF)

New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series

Bioorganic & medicinal chemistry letters, 2012-03, Vol.22 (5), p.1860-1863

2012

Volltextzugriff (PDF)

Abstract 140: Discovery and biological evaluation of PQR530, a highly potent dual pan-PI3K/mTORC1/2 inhibitor

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.140-140

2017

Volltextzugriff (PDF)

A generic remote sensing approach to derive operational essential biodiversity variables (EBVs) for conservation planning

Methods in ecology and evolution, 2018-08, Vol.9 (8), p.1822-1836

2018

Volltextzugriff (PDF)

Entry into a new class of protein kinase inhibitors by pseudo ring design

Bioorganic & medicinal chemistry, 2008-02, Vol.18 (3), p.897-900

2008

Volltextzugriff (PDF)

Abstract 1336: Structure-activity relationship studies, synthesis, and biological evaluation of PQR620, a highly potent and selective mTORC1/2 inhibitor

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1336-1336

2016

Volltextzugriff (PDF)

Abstract 159: Pharmacological characterization of the selective, orally bioavailable, potent dual PI3K/mTORC1/2 inhibitor PQR530

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.159-159

2017

Volltextzugriff (PDF)

Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases

Molecular cancer therapeutics, 2016-10, Vol.15 (10), p.2334-2343

2016

Volltextzugriff (PDF)

Abstract 393A: Pharmacological characterization of the selective, orally bioavailable, potent mTORC1/2 inhibitor PQR620

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.393-393A

2016

Volltextzugriff (PDF)

Abstract 4514: PQR309: A potent, brain-penetrant, dual pan-PI3K/mTOR inhibitor with excellent oral bioavailability and tolerability

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4514-4514

2015

Volltextzugriff (PDF)

Abstract DDT01-01: Discovery of CGM097 as a novel Mdm2 inhibitor

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.DDT01-01-DDT01-01

2014

Volltextzugriff (PDF)

Abstract 2664: PQR309: Structure-based design, synthesis and biological evaluation of a novel, selective, dual pan-PI3K/mTOR inhibitor

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2664-2664

2015

Volltextzugriff (PDF)

An approach to the structure of quasicrystals: A single crystal X-ray and neutron diffraction study of the R-Al5CuLi3 phase

Physica. B, Condensed matter, 1988-10, Vol.153 (1-3), p.136-142

1988

Volltextzugriff (PDF)

Abstract 1797: Discovery of NVP-CGM097, a highly potent and optimized small molecule inhibitor of Mdm2 under evaluation in a Phase I clinical trial

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1797-1797

2014

Volltextzugriff (PDF)

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Journal of medicinal chemistry, 2000-06, Vol.43 (12), p.2310-2323

2000

Volltextzugriff (PDF)

2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors

Bioorganic & medicinal chemistry letters, 2010-03, Vol.20 (5), p.1724-1727

2010

Volltextzugriff (PDF)

Abstract 1922: 2-Aminothiazoles as potent and selective PI3Kalpha inhibitors: Discovery of NVP-BYL719 and structural basis for the isoform selectivity

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1922-1922

2012

Volltextzugriff (PDF)

Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design

Journal of medicinal chemistry, 2004-09, Vol.47 (20), p.4810-4813

2004

Volltextzugriff (PDF)

New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development

Journal of medicinal chemistry, 1998-08, Vol.41 (18), p.3387-3401

1998

Volltextzugriff (PDF)

Novel β-lactam derivatives: Potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome

Bioorganic & medicinal chemistry letters, 2007-01, Vol.17 (2), p.358-362

2007

Volltextzugriff (PDF)

Why Trust Science?

Oreskes, Naomi

2021

Volltextzugriff (PDF)

1 – 25 von 1.114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(894)
Mit Volltextzugriff
(1.018)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(659)
Life Sciences & Biomedicine
(520)
Humans
(389)
Female
(203)
Male
(202)
Middle Aged
(144)
Adult
(134)
Technology
(117)
Biological And Medical Sciences
(109)
Aged
(101)
Medical Sciences
(100)
Computer Science
(80)
Life Sciences
(77)
Animals
(76)
Physical Sciences
(74)
Computer Science, Artificial Intelligence
(59)
Computer Science, Theory & Methods
(58)
Cardiovascular System & Cardiology
(56)
Risk Factors
(54)
Surgery
(54)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Fast Unsupervised Multi-Scale Characterization of Urban Landscapes Based on Earth Observation Data

Complementarity between Textural and Radiometric Indices From Airborne and Spaceborne Multi VHSR Data: Disentangling the Complexity of Heterogeneous Landscape Matrix

Monitoring and Characterizing Heterogeneous Mediterranean Landscapes with Continuous Textural Indices Based on VHSR Imagery

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines

Integration of ADAS Into One Central Platform Controller

New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series

Abstract 140: Discovery and biological evaluation of PQR530, a highly potent dual pan-PI3K/mTORC1/2 inhibitor

A generic remote sensing approach to derive operational essential biodiversity variables (EBVs) for conservation planning

Entry into a new class of protein kinase inhibitors by pseudo ring design

Abstract 1336: Structure-activity relationship studies, synthesis, and biological evaluation of PQR620, a highly potent and selective mTORC1/2 inhibitor

Abstract 159: Pharmacological characterization of the selective, orally bioavailable, potent dual PI3K/mTORC1/2 inhibitor PQR530

Debio 0617B Inhibits Growth of STAT3-Driven Solid Tumors through Combined Inhibition of JAK, SRC, and Class III/V Receptor Tyrosine Kinases

Abstract 393A: Pharmacological characterization of the selective, orally bioavailable, potent mTORC1/2 inhibitor PQR620

Abstract 4514: PQR309: A potent, brain-penetrant, dual pan-PI3K/mTOR inhibitor with excellent oral bioavailability and tolerability

Abstract DDT01-01: Discovery of CGM097 as a novel Mdm2 inhibitor

Abstract 2664: PQR309: Structure-based design, synthesis and biological evaluation of a novel, selective, dual pan-PI3K/mTOR inhibitor

An approach to the structure of quasicrystals: A single crystal X-ray and neutron diffraction study of the R-Al5CuLi3 phase

Abstract 1797: Discovery of NVP-CGM097, a highly potent and optimized small molecule inhibitor of Mdm2 under evaluation in a Phase I clinical trial

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors

Abstract 1922: 2-Aminothiazoles as potent and selective PI3Kalpha inhibitors: Discovery of NVP-BYL719 and structural basis for the isoform selectivity

Entry into a New Class of Potent Proteasome Inhibitors Having High Antiproliferative Activity by Structure-Based Design

New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development

Novel β-lactam derivatives: Potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome

Why Trust Science?

Suchergebnisse filtern